Biotech & AI drug discoveryNature Medicine

A live biotherapeutic product for adult allogeneic hematopoietic cell transplantation recipients: a partially randomized, placebo-controlled phase 1b trial

A partially randomized, placebo-controlled phase 1b trial tested a live biotherapeutic product in adult allogeneic hematopoietic cell transplantation recipients. The available information describes the trial design only and does not report outcomes.

AI summary · generated only from source feed metadata; consult original

Source published2026-11-03T00:00:00+00:00

Published here2026-11-04T01:38:52+00:00

Original source

Nature Medicine

Media report · consult original reporting

Read the original ↗https://www.nature.com/articles/s41591-026-04686-y

Original headline

A live biotherapeutic product for adult allogeneic hematopoietic cell transplantation recipients: a partially randomized, placebo-controlled phase 1b trial

AI bilingual edit · consult original

Headlines are indexed or machine translated, not independent verification of scientific results. Medical news is not clinical advice. Distinguish interstellar concepts from demonstrated space technology using the original source.